Scientists from the Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences together with colleagues from St. Petersburg have developed a new method of treatment of severe patients with coronavirus pneumonia. The press-service of the university informed about it today, on October 9.
Instead of the usual artificial pulmonary ventilation (AV) device, they designed a device where a heated helium-oxygen mixture (30% helium, 70% oxygen) is used for AV. According to Valery Chereshnev, President of the Eurasian Research Institute of the Ural State University of Economics, helium-oxygen mixture began to be used in medicine 50-60 years ago to treat bronchial asthma, severe pneumonia, and other diseases. Scientists’ know-how is that together with the medicinal mixture, a heating element is built into the device because coronavirus is very sensitive to high temperatures.
Scientists from the Lomonosov Military Medical Academy took part in the development. S.M. Kirov Military Medical Academy of St. Petersburg, employees of St. Petersburg Innovation Center, in particular Sergey Onikenko. Currently, this patent invention is being clinically tested.
“Within two or three months after its manufacture the devices will be tested according to the drawings, then they will appear in hospitals specializing in the treatment of Covid-19,” – explained Chereshnev.
There are ten such devices in Komi now, and they are also available in hospitals in St. Petersburg and the city of Sosnovy Bor (Leningrad region).
Also, Chereshnev told about the new drug “Triazaverin”, developed together with the Ural scientists. According to him, it showed good results in the treatment of coronavirus, because it “perfectly stimulates the immune system”.